MedPath

A randomized controlled study of acupoint selection by extracorporeal shock wave along meridians in the treatment of heel pai

Phase 1
Conditions
Heel pain
Registration Number
ITMCTR1900002811
Lead Sponsor
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. meet the diagnostic criteria of western medicine:
(1) clinical manifestations: slow onset, mostly in the middle-aged and elderly obese people, mostly on one side, with a history of several months or years; pain in the heel, aggravated by walking; typical people stand up in the morning or sit up for a long time, severe pain in the heel, relieved after walking for a while, but aggravated after walking or standing for a long time;
(2) signs: no Obvious swelling or slight swelling, tenderness on the metatarsal surface or side of the calcaneus; if the calcaneus is hyperosteogeny, the bony process can be touched;
(3) X-ray manifestations: hyperosteogeny is common.
2. the first time of onset, the course of disease is within 1 month;
3. the age is more than 18 years old;
4. sign the informed consent, agree to receive treatment and cooperate with the follow-up.

Exclusion Criteria

1. patients with hemorrhagic diseases and coagulation disorders may cause local tissue bleeding, untreated, incurable or incurable hemorrhagic diseases;
2. patients with local skin damage, local or systemic inflammation or infection, and joint infection may occur;
3. ankle injury caused by acute trauma, such as muscle, tendon rupture, fracture, etc;
4. serious primary diseases such as heart, cerebrovascular disease, lung, liver, kidney and hematopoietic system;
5. osteomyelitis of calcaneus, tuberculosis of calcaneus, tumor of calcaneus and local infection;
6. psychopaths.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AOFOS;VAS;
Secondary Outcome Measures
NameTimeMethod
SF36 score;
© Copyright 2025. All Rights Reserved by MedPath